Human Cord Blood Mononuclear Cells

Description: CD34 is a well-known cell surface marker for primitive and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial progenitors. Within cord blood, there are CD34+ and another population that is both CD34+/CD133+. Creative Bioarray provides CD34+/CD133+ progenitor cells in a phenotypically undifferentiated state. The progenitor cells are derived from cord blood of consented healthy donors and each vial contains at least 1*10^5 cells.

Description: HUASMC from Creative Bioarray are isolated from human umbilical arteries. HUASMC are cryopreserved at the end of secondary culture and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HUASMC are characterized by immunofluorescent method with antibodies to ?-smooth muscle actin and desmin. HUASMC are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HUASMC are guaranteed to further expand for 15 population doublings at the condition provided by Creative Bioarray.

Description: HUVSMC from Creative Bioarray are isolated from human umbilical veins. HUVSMC are cryopreserved at the end of secondary culture and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HUVSMC are characterized by immunofluorescent method with antibodies to ?-smooth muscle actin and desmin. HUVSMC are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HUVSMC are guaranteed to further expand for 15 population doublings at the condition provided by Creative Bioarray.

Description: Human umbilical cord blood mononuclear cells are isolated from umbilical cord blood. Human umbilical cord blood mononuclear cells are from a single donor. These cells contain CD34+ stem cells. They enable researchers to produce various cell types of the hematopoietic lineage using standard published protocols. These cells may be used for various studies on hematopoiesis, differentiation, angiogenesis, colony formation, and surface marker expression. Presently, they are widely investigated for various therapeutic applications.
Development period: Post Natal

Description: Human CD34+ umbilical cord blood cells are isolated from umbilical cord blood and purified using magnetic cell separation. Human CD34+ umbilical cord blood cells are from a single donor and are >90% pure populations as confirmed by FACS analysis. These cells are regularly used to reconstitute the hematopoietic system in infants and small children with malignancies. These cells also enable researchers to produce various cell types using standard published protocols. Additionally, CD34+ umbilical cord blood cells may be used for various studies on hematopoiesis, differentiation, angiogenesis, colony formation, and surface marker expression. Presently, they are widely investigated for various therapeutic applications.
Development period: Postnatal

Description: Human CD34+ umbilical cord blood cells are isolated from umbilical cord blood and purified using magnetic cell separation. Human CD34+ umbilical cord blood cells are >90% pure populations as confirmed by FACS analysis. These cells are regularly used to reconstitute the hematopoietic system in infants and small children with malignancies. These cells also enable researchers to produce various cell types using standard published protocols. Additionally, CD34+ umbilical cord blood cells may be used for various studies on hematopoiesis, differentiation, angiogenesis, colony formation, and surface marker expression. Presently, they are widely investigated for various therapeutic applications.
Development period: Postnatal